Thermo Fisher Scientific announced that it is investing $150M in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing. Included in the site expansion projects are Monza and Ferentino, Italy, and Greenville, North Carolina. In response to customer requests, each of the sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next 24 months.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.